EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Baicalin attenuated metabolic dysfunction‐associated fatty liver disease by suppressing oxidative stress and inflammation via the p62–Keap1–Nrf2 signalling pathway in db/db mice

Wen-Jing Liu, Wei-Wen Chen, Jia-Ying Chen, Yi-Bin Sun, Dennis Chang, Chen-Xiang Wang, Jin-Dong Xie, Wei Lin, Shao-Hua Li, Wen Xu, Yan-Xiang Lin, Yan-Fang Zheng iD and 2 more

Phytotherapy Research · 2025-04 · 39 (4) · 1663-1678

DOI: 10.1002/ptr.8010 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2023-09-11. Written by Wen-Jing Liu and 13 co-authors. Institution: College of Pharmacy, Fujian Key Laboratory of Chinese Materia Medica, Fujian University of Traditional Chinese Medicine, Fuzhou, China. Major MEDLINE topics: Flavonoids, Oxidative Stress, Non-alcoholic Fatty Liver Disease. Cited 33 times so far (Crossref); 62 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Collaborative Innovation Platform Project of Fuxiaquan National Innovation Demonstration Zone, National Natural Science Foundation of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Metabolic dysfunction‐associated fatty liver disease (MAFLD) is the main cause of chronic liver disease. Baicalin (Bai), a bioactive molecule found in Scutellaria baicalensis Georgi, possesses antioxidant and antiinflammatory properties. These activities suggest Bai could be a promising therapeutic agent against NAFLD; however, its specific effects and underlying mechanism are still not clear. This study aims to explore the effect of Bai to attenuate MAFLD and associated molecular mechanisms. Bai (50, 100 or 200 mg/kg) was orally administered to db / db mice with MAFLD for 4 weeks or db/m mice as the normal control. Bai markedly attenuated lipid accumulation, cirrhosis and hepatocytes apoptosis in the liver tissues of MAFLD mice, suggesting strong ability to attenuate MAFLD. Bai significantly reduced proinflammatory biomarkers and enhanced antioxidant enzymes, which appeared to be modulated by the upregulated p62‐Keap1‐Nrf2 signalling cascade; furthermore, cotreatment of Bai and all‐trans‐retinoic acid (Nrf2 inhibitor) demonstrated markedly weakened liver protective effects by Bai and its induced antioxidant and antiinflammatory responses. The present study supported the use of Bai in attenuating MAFLD as a promising therapeutic agent, and its strong mechanism of action in association with the upregulating the p62‐keap1‐Nrf2 pathway.

Subjects

MeSH terms (MEDLINE)

FlavonoidsOxidative StressNon-alcoholic Fatty Liver DiseaseAnimalsNF-E2-Related Factor 2Kelch-Like ECH-Associated Protein 1Signal TransductionMiceMaleLiverInflammationSequestosome-1 ProteinAnti-Inflammatory AgentsAntioxidantsMice, Inbred C57BLApoptosis

Author keywords

BaicalinMAFLDNrf2inflammationoxidative stresstype 2 diabetes mellitus

Substances

NF-E2-Related Factor 2baicalinFlavonoidsKelch-Like ECH-Associated Protein 1Nfe2l2 protein, mouseKeap1 protein, mouseSequestosome-1 ProteinAnti-Inflammatory AgentsAntioxidantsSqstm1 protein, mouse

Authors and institutions

  • College of Pharmacy, Fujian Key Laboratory of Chinese Materia Medica, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
  • NICM Health Research Institute, Western Sydney University, Westmead, New South Wales, Australia.
  • Science and Technology Innovation and Transformation Center, Fujian University of Traditional Chinese Medicine, Fuzhou, China.

ORCID profiles: Yan-Fang Zheng, Xian Zhou

Funding

  • Collaborative Innovation Platform Project of Fuxiaquan National Innovation Demonstration Zone
  • National Natural Science Foundation of China

Cite

APA

Liu, W. J., Chen, W. W., Chen, J. Y., Sun, Y. B., Chang, D., Wang, C. X., Xie, J. D., Lin, W., Li, S. H., Xu, W., Lin, Y. X., Zheng, Y. F., Zhou, X., & Huang, M. Q. (2025). Baicalin attenuated metabolic dysfunction‐associated fatty liver disease by suppressing oxidative stress and inflammation via the p62–Keap1–Nrf2 signalling pathway in db/db mice. Phytotherapy Research, 39(4), 1663-1678. https://doi.org/10.1002/ptr.8010

Vancouver

Liu WJ, Chen WW, Chen JY, Sun YB, Chang D, Wang CX, et al. Baicalin attenuated metabolic dysfunction‐associated fatty liver disease by suppressing oxidative stress and inflammation via the p62–Keap1–Nrf2 signalling pathway in db/db mice. Phytotherapy Research. 2025;39(4):1663-1678. doi:10.1002/ptr.8010

BibTeX
@article{Liu2025,
  author = {Liu, Wen-Jing and Chen, Wei-Wen and Chen, Jia-Ying and Sun, Yi-Bin and Chang, Dennis and Wang, Chen-Xiang and Xie, Jin-Dong and Lin, Wei and Li, Shao-Hua and Xu, Wen and Lin, Yan-Xiang and Zheng, Yan-Fang and Zhou, Xian and Huang, Ming-Qing},
  title = {Baicalin attenuated metabolic dysfunction‐associated fatty liver disease by suppressing oxidative stress and inflammation via the p62–Keap1–Nrf2 signalling pathway in db/db mice},
  journal = {Phytotherapy Research},
  year = {2025},
  volume = {39},
  number = {4},
  pages = {1663--1678},
  doi = {10.1002/ptr.8010}
}
Start for free →